AAS
UTHR icon

Ameritas Advisory Services’s United Therapeutics UTHR Stock Holding History

Ameritas Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.3K Sell
115
-5,124
-98% -$2.89M ﹤0.01% 1218
2026
Q1 		$3.11M Buy
5,239
+98
+2% +$48.8K 0.12% 165
2025
Q4 		$2.5M Buy
5,141
+5,114
+18,941% +$2.38M 0.09% 197
2025
Q3 		$11.3K Sell
27
-5
-16% -$1.68K ﹤0.01% 1614
2025
Q2 		$9.2K Buy
+32
New +$9.56K ﹤0.01% 2048
2023
Q2 		– Sell
-5
Closed -$1.14K – 2425
2023
Q1 		$1.14K Buy
+5
New +$1.23K ﹤0.01% 2525

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Ameritas Advisory Services's UTHR Position: Q2 2026 in Review

Ameritas Advisory Services reduced its United Therapeutics (UTHR) stake by 98% in Q2 2026, selling an estimated $2.89M and leaving 115 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1218.

Ameritas Advisory Services first reported a position in UTHR in Q1 2023 and has held it in 6 quarters since. The position peaked at $3.11M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Ameritas Advisory Services held 115 shares of United Therapeutics worth $62.3K as of Q2 2026.
  • Ameritas Advisory Services sold 5,124 United Therapeutics shares in Q2 2026, an estimated $2.89M.
  • United Therapeutics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1218 holding.
  • Ameritas Advisory Services first reported a position in United Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • Ameritas Advisory Services's United Therapeutics position peaked at $3.11M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.